Prognostic Markers for Gallbladder Cancer Reveal Need for Improved Surveillance

Gallbladder cancer patients undergoing resection between 2002 and 2021 were studied to determine the prognostic significance of baseline serum carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA) levels. Researchers from Ohio State University found that individuals with low CA19-9/low CEA levels had the most favorable 3-year recurrence-free survival (RFS) after surgery, while those with high CA19-9/high CEA levels had the worst RFS. These findings highlight the need for better markers to monitor for recurrence following gallbladder cancer resection.

Key Takeaways:

  • The study involved 194 patients who underwent resection of gallbladder cancer between 2002 and 2021.
  • Median preoperative CA19-9 and CEA levels were 18.8 U/mL (IQR 7.0-88.0) and 2.2 ng/mL (IQR 1.3-3.8), respectively.
  • 92 (47.4%) and 67 (34.5%) patients had elevated CA19-9 ( > 20 U/mL) and CEA ( > 3 ng/mL) levels before surgery, respectively.
  • Individuals with low CA19-9/low CEA had the most favorable 3-year RFS (74.5%) after surgery, followed by those with either high CA19-9 (high CA19-9/low CEA: 41.6%) or high CEA (low CA19-9/high CEA: 60.9%) levels.
  • Patients with high CA19-9/high CEA had the worst 3-year RFS (21.5%) following surgery.

Statistics:

  • 47.4% of patients had elevated preoperative CA19-9 levels.
  • 34.5% of patients had elevated preoperative CEA levels.
  • The negative predictive value of normal vs. normalized CA19-9 levels relative to the development of recurrence within 1 year after surgery was evaluated.

Sources:

  • "Recurrence After Gallbladder Cancer Resection: Prognostic Impact of Ca19-9 and Cea Levels At Baseline and During Surveillance." Journal of Surgical Oncology, 2025.
  • Ohio State University, Ohio State University Wexner Medical Center, Dept. of Surgery, Columbus, OH 43210, United States.
  • Diamantis I. Tsilimigras, Odysseas P. Chatzipanagiotou, Timothy M. Pawlik, Andrea Ruzzenente, Federico Aucejo, Hugo P. Marques, Joao Bandovas, Tom Hugh, Nazim Bhimani, Shishir K. Maithel, Minoru Kitago, and Itaru Endo.